Intuniv Uses
Links shared publicly online about this topic
Intuniv for ADHD: Metabolic Challenges
corepsychblog.com — “This post is the fifth, with four others, documenting Intuniv Overview, Dosing Details, Drug Interactions and Addiction Indications. Please review all of these posts for more informed use of Intuniv” View full resource at corepsychblog.com
Most Recently Shared on February 1, 2010 at 11:01 am By:
Educator, Writer, Neuroscientist, Child and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive foundation for treatment interventions and recommendations. If you don't look, you can't see. Mind diagnosis evolves beyond polemics." /> Dr Charles Parker Doctor, Psychiatrist, Physician, and Active Health Library
New post: Intuniv for ADHD: Metabolic Challenges http://goo.gl/fb/oOAJ
Intuniv for ADHD: Metabolic Challenges
corepsychblog.com — “This post is the fifth, with four others, documenting Intuniv Overview, Dosing Details, Drug Interactions and Addiction Indications. Please review all of these posts for more informed use of Intuniv” View full resource at corepsychblog.com
Most Recently Shared on February 4, 2010 at 9:50 am By:
Educator, Writer, Neuroscientist, Child and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive foundation for treatment interventions and recommendations. If you don't look, you can't see. Mind diagnosis evolves beyond polemics." /> Dr Charles Parker Doctor, Psychiatrist, Physician, and Active Health Library
Many links on info re: Intuniv for ADHD: Metabolic Challenges http://bit.ly/d9jFyi including addiction, dosing, tenex #ADHD #neuroscience
Shire: FDA Oks INTUNIV ER Tablets For Use As Adjunctive Therapy To Stimulants
rttnews.com — “Shire plc (SHP.L, SHPGY) said that the US FDA approved the use of once-daily INTUNIV Extended-Release Tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder, also known as ADHD, in children and adolescents ages 6 to 17 as part of a total treatment program.” View full resource at rttnews.com
Most Recently Shared on February 28, 2011 at 3:18 pm By:
Peter H Brown Doctor and Psychologist
Shire: FDA Oks INTUNIV ER Tablets For Use As Adjunctive Therapy To Stimulants http://bit.ly/dUc4ur #ADHD
Shire ADHD treatment Intuniv approved for use with a stimulant | Markets | Market News | Canadian Business Online
canadianbusiness.com — “Irish drugmaker Shire Plc. said Monday the U.S. Food and Drug Administration approved the use of att” View full resource at canadianbusiness.com
Most Recently Shared on March 1, 2011 at 7:04 am By:
Peter H Brown Doctor and Psychologist
Shire ADHD treatment Intuniv approved for use with a stimulant http://bit.ly/hlBbwS #ADHD
Intuniv for ADHD: Metabolic Challenges | CorePsych Blog
corepsychblog.com — “This post is the fifth, with four others, documenting Intuniv Overview, Dosing Details, Drug Interactions and Addiction Indications. Please review all of these posts for more informed use of Intuniv” View full resource at corepsychblog.com
Most Recently Shared on October 31, 2010 at 5:22 pm By:
Educator, Writer, Neuroscientist, Child and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive foundation for treatment interventions and recommendations. If you don't look, you can't see. Mind diagnosis evolves beyond polemics." /> Dr Charles Parker Doctor, Psychiatrist, Physician, and Active Health Library
Intuniv for ADHD: Metabolic Challenges - 63 Comments on dosing strategies http://bit.ly/ctGNUW #ADHD #medications #Medications
Intuniv gains indication as adjunctive therapy in ADHD - ONA
oncologynurseadvisor.com — “Shire announced that the FDA has approved Intuniv (guanfacine extended-release tablets) for use as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6--17 years as part of a total treatment program.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 28, 2011 at 3:40 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
Intuniv gains indication as adjunctive therapy in ADHD http://goo.gl/fb/srbUs
FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets For Use As Adjunctive Therapy To Stimulants For The Treatment Of ADHD
medicalnewstoday.com — “Shire plc, (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the use of once-daily INTUNIV® (gu” View full resource at medicalnewstoday.com
Most Recently Shared on March 1, 2011 at 8:33 pm By:
FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets For Use As Adjunctive Therapy To Stimulants F... http://bit.ly/ePyJtA #adhd
Intuniv gains indication as adjunctive therapy in ADHD - MPR
empr.com — “Shire announced that the FDA has approved Intuniv (guanfacine extended-release tablets) for use as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6--17 years as part of a total treatment program.” View full resource at empr.com
Most Recently Shared on February 28, 2011 at 3:44 pm By:
MPR News: Intuniv gains indication as adjunctive therapy in ADHD: Shire announced that the FDA has approved Intu... http://bit.ly/eyR7Gr
Google Sidewiki entry about Intuniv for ADHD: Understanding Tenex, Guanfacine and Alpha 2
google.com — “Some very interesting comments and updates are following the ADHD crew here - some useful points on Intuniv as well as the larger question of specific testing.” View full resource at google.com
Most Recently Shared on January 17, 2010 at 11:15 pm By:
Educator, Writer, Neuroscientist, Child and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive foundation for treatment interventions and recommendations. If you don't look, you can't see. Mind diagnosis evolves beyond polemics." /> Dr Charles Parker Doctor, Psychiatrist, Physician, and Active Health Library
Over 100 Comments-Sidewiki entry on "Intuniv for ADHD: Understanding Tenex, Guanfacine and Alpha 2" http://bit.ly/78jSJq
PharmaLive: FDA Approves Intuniv (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
pharmalive.com — “PharmaLive: FDA Approves Intuniv (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents” View full resource at pharmalive.com
Most Recently Shared on February 28, 2011 at 7:27 pm By:
PharmaLive Pharma and Health News
Daily Advantage - FDA OKs Wider Intuniv Use - http://tinyurl.com/4on7zsc
Shire Announces FDA Approval of Once-Daily Intuniv (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
drugs.com — “Intuniv (guanfacine) is used to treat Attention-Deficit/Hyperactivity Disorder in children and adolescents aged 6 to 17 years. Includes Intuniv side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 4, 2009 at 12:32 am By:
FDA Approves Intuniv (guanfacine) for the Treatment of ADHD in Children and Adolescents - http://bit.ly/EObbC
FDA approves guanfacine ER tablets to treat ADHD in children, teens - - Drug Topics
drugtopics.modernmedicine.com — “FDA approved the use of once-daily guanfacine (Intuniv, Shire) extended-release tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder in children and adolescents aged 6 to 17 years as part of a total treatment program.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on March 2, 2011 at 7:52 pm By:
FDA approves guanfacine ER tablets to treat ADHD in children, teens: FDA approved the use of once-daily gu... http://bit.ly/hRwbtM #adhd
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Educator, Writer, Neuroscientist, Child and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive foundation for treatment interventions and recommendations. If you don't look, you can't see. Mind diagnosis evolves beyond polemics." />
Dr Charles Parker
Dr. Parker is an Educator, Writer, Neuroscientist, Child and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive foundation for treatment interventions and recommendations. If you don't look, you can't see. Mind diagnosis evolves beyond polemics.
-
Educator, Writer, Neuroscientist, Child and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive foundation for treatment interventions and recommendations. If you don't look, you can't see. Mind diagnosis evolves beyond polemics." />
Dr Charles Parker
Dr. Parker is an Educator, Writer, Neuroscientist, Child and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive foundation for treatment interventions and recommendations. If you don't look, you can't see. Mind diagnosis evolves beyond polemics.
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
Advertisement
